Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELMD
ELMD logo

ELMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Electromed Inc (ELMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
23.410
1 Day change
-3.82%
52 Week Range
30.730
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Electromed Inc (ELMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and lack of significant negative catalysts make it a solid choice for long-term growth.

Technical Analysis

The MACD is above 0 and positively contracting, indicating a mild bullish trend. RSI is neutral at 58.692, and moving averages are converging, suggesting no strong directional bias. The stock is trading near its resistance level of R1: 24.739, with support at S1: 23.226.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
13
Buy
1

Positive Catalysts

  • Strong financial performance in Q2 2026, with revenue up 16.25% YoY, net income up 40.29% YoY, and EPS up 45.45% YoY.

  • Analyst upgrade from Roth Capital with a price target increase to $38, indicating confidence in the company's growth potential.

Neutral/Negative Catalysts

  • No significant hedge fund or insider trading trends, indicating a lack of strong institutional interest.

  • Slight pre-market and regular market price decline, though post-market recovery mitigates this.

Financial Performance

Electromed reported strong growth in Q2 2026, with revenue increasing to $18.897 million (+16.25% YoY), net income rising to $2.761 million (+40.29% YoY), EPS improving to $0.32 (+45.45% YoY), and gross margin expanding to 78.42% (+0.95% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital recently raised the price target for ELMD to $38 from $36, maintaining a Buy rating. The analyst cited strong performance in the company's core homecare business as a key driver of growth.

Wall Street analysts forecast ELMD stock price to rise
3 Analyst Rating
Wall Street analysts forecast ELMD stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 24.340
sliders
Low
36
Averages
37.33
High
38
Current: 24.340
sliders
Low
36
Averages
37.33
High
38
Roth Capital
Buy
maintain
$36 -> $38
AI Analysis
2026-02-11
Reason
Roth Capital
Price Target
$36 -> $38
AI Analysis
2026-02-11
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $38 from $36 and keeps a Buy rating on the shares. The company reported results that were above expectations, largely driven by strong performance in the company's core homecare business, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$35 -> $36
2025-11-13
Reason
Roth Capital
Price Target
$35 -> $36
2025-11-13
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $36 from $35 and keeps a Buy rating on the shares. The company's Q1 results were above expectations and the management reiterated its goal to drive double-digit top-line growth and expanded operating leverage, the analyst tells investors in a research note. The company's best-in-class high frequency chest wall oscillation device continues to take share in a highly underdiagnosed bronchiectasis market, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELMD
Unlock Now

People Also Watch